Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
142.44
+1.19 (0.84%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Neurocrine Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $214 | Buy | Reiterates | $214 | +50.24% | Oct 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $210 | Buy | Reiterates | $210 | +47.43% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $187 | Buy | Maintains | $187 | +31.28% | Oct 9, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $207 | Buy | Initiates | $207 | +45.32% | Oct 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $220 | Buy | Maintains | $220 | +54.45% | Sep 29, 2026 |
| UBS | UBS | Buy Reiterates $231 → $214 | Buy | Reiterates | $231 → $214 | +50.24% | Sep 29, 2026 |
| Bernstein | Bernstein | Buy Maintains $218 | Buy | Maintains | $218 | +53.05% | Sep 26, 2026 |
Unknown Analyst CCB Intl. No rating | CCB Intl. | Buy Initiates $188 | Buy | Initiates | $188 | +31.99% | Sep 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.